Subject: Fwd: Confidential RSTP Quarterly Update
From: "John DeLoche" <[email-masked]>
To: "Hunter Biden" <[email-masked]>, "Devon Archer" <[email-masked]>, "Neil Callahan" <[email-masked]>, "Eric Schwerin" <[email-masked]>, "Rob Walker" <[email-masked]>, "Arlene Busch" <[email-masked]>, "Marianna Fazylova" <[email-masked]>
Date: Sun, 29 Jan 2012 17:55:17 -0800

FYI some positive feedback on the fund from Nathaniel de Rothschild.

---------- Forwarded message ----------
From: John DeLoche <[email-masked]>
Date: Sun, Jan 29, 2012 at 5:50 PM
Subject: Re: Confidential RSTP Quarterly Update
To: [email-masked]
Cc: [email-masked], [email-masked], [email-masked]

Nathaniel,

That is great news. Please feel free to call or send any follow up
questions. We have an updated version of the presentation I will send you
and Pierre.

We did meet with Bob in Menlo Park last week. I introduced him to  Neil as
well as Hunter Biden, who runs our business development team.

Best,

John

On Sun, Jan 29, 2012 at 5:40 PM, <[email-masked]> wrote:

> **
> Many thanks , that is good news.BTW Pierre is away but I think when he
> gets back that we will make the final decision to invest in your fund or
> not .It is looking positive right now.
> All the best
> Nathaniel
>
> PS Have you discussed the fund with Bob ?
>
>  In a message dated 1/29/2012 9:33:37 P.M. Eastern Daylight Time,
> [email-masked] writes:
>
>  Hi Nathaniel,
>
> It was great to catch up a few weeks ago. Attached is an updated version
> of our slide presentation for your review.
>
> As discussed during our meeting, since closing the investment in Counsyl
> RSTP's business development team has been working closely with the company
> to help them expand their business in key geographies.  Counsyl had a great
> 2011 and strong momentum in Q4. Some highlights include:
>
> *2011 Highlights*
>
>    - 22,400 people screened
>    - 1,270 clinics and hospitals have ordered the UGT as of 12/31/2011
>    - 15% increase in requisition value YoY ($435 to $500)
>    - Introduction of Fragile X screening
>    - Requisition revenue of $11.2 million, 533% growth YoY
>    - Annual gross margin of 65.5%
>    - Invoiced revenue grew 800% from $200k in January to $1.6 million in
>    December
>    - Invoiced revenue run rate of $20 million as of December
>
> *Q4 Highlights:*
>
>    - Gross margins were 70.5% in Q4, increasing from 34% in Q1
>    - 10,492 people screened in Q4, representing requisition growth of 65%
>    QoQ
>    - Requisition revenue of $5.6 million, an increase of 81% QoQ
>    - Raised $28 million Series B round and completed $5 million venture
>    debt financing
>    - Cash flow positive in Q4
>    - Signed 6 year lease on 27,000 square foot facility in South San
>    Francisco
>    - Increased sales team to 34 people
>
> Counsyl expects strong growth and continued profitability in 2012. The
> Company expects its new lab to be fully operational by April, 2012 and to
> be state of the art in terms of automation which will have a positive
> impact on gross margins. The company is hiring aggressively for key sales,
> marketing and lab positions.
>
> Please feel free to call me with any questions.
>
> My best,
>
> John
>
> John DeLoche
> *Managing Director*
> Rosemont Seneca Technology Partners
> One Market, Spear Tower, 36th Floor
> San Francisco, CA 94105
> office: 415 293 8147
> mobile: 415 793 7070
>
> This email communication is privileged and confidential and is intended
> only for the individuals or entities named above. Any unauthorized
> dissemination of any of the contents of this email is strictly prohibited.
> If you are not the intended recipient, please do not read, copy, use or
> disclose to others the contents of this communication. Please notify the
> sender that you have received this e-mail in error and then delete the
> e-mail.
>
>
>
>

-- 
John DeLoche
*Managing Director*
Rosemont Seneca Technology Partners
One Market, Spear Tower, 36th Floor
San Francisco, CA 94105
office: 415 293 8147
mobile: 415 793 7070

This email communication is privileged and confidential and is intended
only for the individuals or entities named above. Any unauthorized
dissemination of any of the contents of this email is strictly prohibited.
If you are not the intended recipient, please do not read, copy, use or
disclose to others the contents of this communication. Please notify the
sender that you have received this e-mail in error and then delete the
e-mail.

-- 
John DeLoche
*Managing Director*
Rosemont Seneca Technology Partners
One Market, Spear Tower, 36th Floor
San Francisco, CA 94105
office: 415 293 8147
mobile: 415 793 7070

This email communication is privileged and confidential and is intended
only for the individuals or entities named above. Any unauthorized
dissemination of any of the contents of this email is strictly prohibited.
If you are not the intended recipient, please do not read, copy, use or
disclose to others the contents of this communication. Please notify the
sender that you have received this e-mail in error and then delete the
e-mail